icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
High Rates of SVR in Treatment-Experienced Patients With Genotype 1 HCV Infection and Cirrhosis After Treatment With Ledipasvir/Sofosbuvir and Vedroprevir With or Without Ribavirin for 8 Weeks
 
 
  Reported by Jules Levin
AASLD 2015 Nov 17 San Francisco
 
Eric Lawitz,1 Fred Poordad,1 Robert H. Hyland,2 Lin Liu,2 Hadas S. Dvory,2 Phillip S. Pang,2 Diana M. Brainard,2 Julio A. Gutierrez1
 
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX 2Gilead Sciences, Inc., Foster City, CA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif